{
  "ptid_time": "099_S_4498_2012-06-13",
  "img_path": "/data/qiuhui/data/adni/images/099_S_4498/2012-06-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,897 mm³, 10.1% above the reference mean. With a Z-score of 0.23 (59.1th percentile), this represents normal volume ; hippocampal volume measures 4,809 mm³, 32.4% below the reference mean. With a Z-score of -2.97 (0.1th percentile), this represents significant atrophy; whole brain volume measures 896,700 mm³, 8.0% below the reference mean. With a Z-score of -1.01 (15.7th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,001 mm³, 18.3% below the reference mean. With a Z-score of -1.12 (13.1th percentile), this represents mild atrophy; fusiform gyrus volume measures 13,191 mm³, 22.5% below the reference mean. With a Z-score of -2.04 (2.0th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,756 mm³, 17.8% below the reference mean. With a Z-score of -1.55 (6.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 77.5 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 28.0. MoCA: 21.0. Logical Memory: 6.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.51 SUVR (profound elevated); Amyloid beta: 876.60 pg/mL (normal ); Total tau: 370.50 pg/mL (moderate elevated); Phosphorylated tau: 35.75 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal atrophy (Z-score -2.97) and fusiform gyrus atrophy (Z-score -2.04), along with moderate atrophy in the middle temporal gyrus and mild whole brain and entorhinal cortex atrophy. The MMSE is normal (28/30), but the MoCA (21/30) suggests mild cognitive impairment. Biomarkers indicate normal Aβ but elevated tau (T-tau and P-tau) and profound amyloid deposition (AV45), which is atypical for typical Alzheimer’s but may suggest a tauopathy or mixed pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal atrophy, but with atypical biomarker profile).  \n\n**Confidence:** **Medium** (due to conflicting biomarkers—normal Aβ but elevated tau and AV45—which complicates the typical Alzheimer’s profile).  \n\n*Note:* Further clinical correlation (e.g., neuropsychological testing for memory/executive function) and follow-up imaging would help clarify progression to dementia. If tauopathy (e.g., primary age-related tauopathy [PART] or another non-AD tauopathy) is suspected, additional workup may be needed.",
  "timestamp": "2025-07-26T11:09:37.587641"
}